The clinical course of neuromyelitis optica (Devic's syndrome).
about
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsConnexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis opticaComparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosisAntibody to aquaporin 4 in the diagnosis of neuromyelitis opticaA new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterizationThe history of neuromyelitis opticaAquaporin 4 and neuromyelitis opticaIgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channelClinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosisOptical coherence tomography differs in neuromyelitis optica compared with multiple sclerosisDemyelination in rheumatic diseasesClinical proteomics of enervated neuronsThe Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future PerspectivesWhat do we know about brain contrast enhancement patterns in neuromyelitis optica?Therapy of NMO spectrum disordersNeuromyelitis optica spectrum disorders: An updateAquaporin-4 autoimmunityClinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directionsInternational consensus diagnostic criteria for neuromyelitis optica spectrum disordersAtypical presentations of neuromyelitis opticaEpidemiology of neuromyelitis optica in the world: a systematic review and meta-analysisChallenges and opportunities in designing clinical trials for neuromyelitis opticaSegmentation of the human spinal cordImmunology of neuromyelitis optica: a T cell-B cell collaborationMolecular pathogenesis of neuromyelitis opticaConventional and advanced imaging in neuromyelitis opticaA treatment of neuromyelitis optica (Devic's disease) during pregnancyMRI characteristics of neuromyelitis optica spectrum disorder: an international updateAquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in JapaneseDisseminated encephalomyelitis and multiple sclerosis: two different diseases - a critical reviewType I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosisBrain magnetic resonance imaging abnormalities in neuromyelitis opticaNeuromyelitis optica and asian phenotype of multiple sclerosisHypercomplementemia at relapse in patients with anti-aquaporin-4 antibodyAssociation of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disordersLETM presented with causalgia and ensued by sudden deathLongitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosisAquaporin-4 antibodies are not related to HTLV-1 associated myelopathyEvaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serologyDistinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
P2860
Q21093230-2932664D-863F-48EE-8779-FA2AD0CA257AQ21132530-E4605619-146E-4FAC-B1BD-8F4BB826727FQ21135278-9082A491-9175-49D5-8280-D9C6D60E144AQ21144670-8C5A9082-1334-47E4-9213-D40DDA3CE911Q21245233-9F463345-62E1-4E8F-9050-5AEDC7C6A36EQ21245248-3DC7ADD4-B7BD-41A7-B8FD-26EEC2F911BAQ24613666-78531931-5776-4B74-8026-00FE737AD1FBQ24646531-DD77DA3A-524F-4922-ACEA-E0177D69D388Q24648404-5A70FF41-AF4A-4D74-8E88-D623F0BBA532Q24650437-8D3E9D5B-7F61-4195-BAA2-8C698ED34FE2Q24678418-8E1D9044-6A6B-4264-BC0D-F7F394DD9FDCQ26752052-C643DC45-8781-46A2-B69E-BCAAFD070598Q26767391-EF4A3EA7-C40E-4779-B54B-A91AA916E0C2Q26776278-53A33534-AF5A-4D68-BA03-FC27D075C35AQ26779910-4832DB80-C692-45A1-9355-542A3F9C8E68Q26779913-DB382C29-0B12-49DE-AFB8-9D6E29367B30Q26799559-0A0C9C3F-4396-4DC3-9C2E-225F71FE4BF3Q26824216-C9DF5943-77B1-46A2-AC94-5F40EDE0B8E3Q26824579-E3DC4B63-BC2E-46D0-881A-8F856E5BC3B3Q26827156-9A9AEFEB-44D1-484E-9936-E9B2BADE2C4DQ26861381-F0B98D52-60D9-4FA6-ABD5-814964F7FCC0Q26999708-55BA5A6E-976C-4296-A46C-FC1574AED025Q27007796-7C0EB627-31B6-489B-A64D-5E28C85EE6F0Q27016045-D8B26F29-15B9-401C-9301-32ABA3ECFDBBQ27021535-5E28B08F-8A4B-4087-BB5A-27D1EE45CAC8Q27021822-8B63B815-D611-40D2-85A3-B05BA4AEDC3CQ28067384-2AC690ED-F943-474F-8C69-CA49C9B15462Q28087067-6B571956-C60B-48BC-9D5B-8A087A422A75Q28246073-BF3C20C8-506D-4FF1-888E-06632D3A334AQ28247162-6ADAC8AE-6E29-4827-B1E6-9E6B503215EAQ28251763-2639662D-37A3-4CCF-9645-28A571A22557Q28274907-240DB7EA-755F-4059-B074-E8B4594B7CD4Q28300078-62AA0E35-1E8B-4385-8776-E0D84B21A5F8Q28301662-29300280-BE13-4E74-BC7B-45F5D5B4EE19Q28306660-135571E2-7D2C-441D-B7EB-9ABD817F9A77Q28559462-8E779782-3216-4983-9D1C-15A3AFB1BCE1Q28647496-721388D9-9386-4419-B584-56E467BFEADFQ28727305-127920CD-BD56-4485-830C-1CF04D64302EQ28728565-F3D65CC0-20EB-4E36-A12C-F6FC353FB00BQ29010429-8F1D3D48-3767-4361-A5E9-D12B1BDB6C81
P2860
The clinical course of neuromyelitis optica (Devic's syndrome).
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The clinical course of neuromyelitis optica (Devic's syndrome).
@ast
The clinical course of neuromyelitis optica (Devic's syndrome).
@en
type
label
The clinical course of neuromyelitis optica (Devic's syndrome).
@ast
The clinical course of neuromyelitis optica (Devic's syndrome).
@en
prefLabel
The clinical course of neuromyelitis optica (Devic's syndrome).
@ast
The clinical course of neuromyelitis optica (Devic's syndrome).
@en
P2093
P356
P1433
P1476
The clinical course of neuromyelitis optica (Devic's syndrome).
@en
P2093
Hogancamp WF
O'Brien PC
Weinshenker BG
Wingerchuk DM
P304
P356
10.1212/WNL.53.5.1107
P407
P577
1999-09-01T00:00:00Z